Stille AB (STIL.XSTO) Dividend Analysis
This company discontinued its dividend after 2022.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
Last dividend was paid in 2022. The company has not paid dividends in the last 3 years.
Does Stille AB (STIL.XSTO) pay a dividend?
Stille AB (STIL.XSTO) stopped paying a dividend after 2022 and pays nothing today. The business does generate free cash flow of SEK 33 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Stille AB (STIL.XSTO) pay a dividend?+
No. Stille AB (STIL.XSTO) does not currently pay a dividend. The last payment in our data was in 2022, and nothing has been paid since.
How does Stille AB return cash to shareholders?+
It largely does not. Stille AB pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Stille AB afford to pay a dividend?+
On the numbers, yes. Stille AB generated SEK 33 million of free cash flow, which is about SEK 3.68 per share. If it paid out half of that, the dividend would be roughly SEK 1.84 per share, a yield of about 8.5% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Stille AB.
Related stocks: Medical Instruments & Supplies
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.